US$ 21.57
lilly glp 1 agonist Eli Lilly's oral GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study finds LLY -0.60% today as Lilly's
Description
To view or add a comment, sign in Ventyx shares jumped about 90% after Phase 2 data showed its NLRP3 drug cut cardiovascular risk results that could draw interest from partner Sanofi

Incorporate lean proteins, complex carbohydrates, healthy fats, and plenty of fruits and vegetables into your meals

Who Might Be at Higher Risk

Madsen LW, Knauf JA, Gotfredsen C, et al

1 References 1
CMS should closely monitor prior authorizations and denials to ensure patients can access GLP-1s
